(6-((Cyclohexylmethyl)amino)pyridin-3-yl)boronic acid

Catalog No. :
ACOGDB693
CAS No. :
1246743-82-7
Molecular Formula :
C12H19BN2O2
Molecular Weight :
234.11

IUPAC Name:(6-((cyclohexylmethyl)amino)pyridin-3-yl)boronic acid

(6-((Cyclohexylmethyl)amino)pyridin-3-yl)boronic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$346.00Login to see priceInquiryInquiry
250mg95%$693.00Login to see priceInquiryInquiry
1g95%$1727.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(6-((Cyclohexylmethyl)amino)pyridin-3-yl)boronic acid
IUPAC Name(6-((cyclohexylmethyl)amino)pyridin-3-yl)boronic acid
MDL No.MFCD23701645
Molecular FormulaC12H19BN2O2
Molecular Weight234.11
SMILESOB(C1=CC=C(NCC2CCCCC2)N=C1)O
InChI KeyBVGKURPRJIHTPB-UHFFFAOYSA-N
Synonym2-(CyclohexylMethylaMino)pyridine-5-boronic acid;(6-((Cyclohexylmethyl)amino)-pyridin-3-yl)boronic acid;Boronic acid, B-[6-[(cyclohexylmethyl)amino]-3-pyridinyl]-
CAS No.1246743-82-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACOGDB693 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEMHZ217 route compound structure diagram
    ACEMHZ217444120-91-6 In Stock
  4. Then
  5. ACOGDB693 route product structure diagram
    ACOGDB6931246743-82-7
Inquiry

2. ACOGDB693 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACATRF163 route compound structure diagram
    ACATRF163223463-14-7 In Stock
  4. Then
  5. ACOGDB693 route product structure diagram
    ACOGDB6931246743-82-7
Inquiry

Comments (0)